ZNF384, a recently found transcription factor with the zinc finger domain, exhibits consistently high expression in lung cancer, hepatocellular cancer (He et al. 2019; Xiao et al. 2022), colorectal cancer (Yan et al. 2022), and osteosarcoma (Gao et al. 2021). Here, ZNF384 is linked to hepatocellular carcinoma.